April Kelly Scott Salama, MD

Publications

Bhatti, MT, and Salama, AKS. "Neuro-ophthalmic side effects of molecularly targeted cancer drugs." Eye (London, England) (October 20, 2017). (Review)

PMID
29052609
Full Text

Hamid, O, Puzanov, I, Dummer, R, Schachter, J, Daud, A, Schadendorf, D, Blank, C, Cranmer, LD, Robert, C, Pavlick, AC, Gonzalez, R, Hodi, FS, Ascierto, PA, Salama, AKS, Margolin, KA, Gangadhar, TC, Wei, Z, Ebbinghaus, S, Ibrahim, N, and Ribas, A. "Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma." European journal of cancer (Oxford, England : 1990) 86 (September 26, 2017): 37-45.

PMID
28961465
Full Text

Beasley, GM, Hu, Y, Youngwirth, L, Scheri, RP, Salama, AK, Rossfeld, K, Gardezi, S, Agnese, DM, Howard, JH, Tyler, DS, Slingluff, CL, and Terando, AM. "Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study." Annals of surgical oncology 24, no. 9 (September 2017): 2728-2733.

PMID
28508145
Full Text

Turner, MC, Rossfeld, K, Salama, AKS, Tyler, D, and Beasley, G. "Can binimetinib, encorafenib and masitinib be more efficacious than currently available mutation-based targeted therapies for melanoma treatment?." Expert opinion on pharmacotherapy 18, no. 5 (April 2017): 487-495. (Review)

PMID
28277830
Full Text

Force, J, and Salama, AK. "First-line treatment of metastatic melanoma: role of nivolumab." ImmunoTargets and therapy 6 (January 2017): 1-10. (Review)

PMID
28243579
Full Text

Shoushtari, AN, Munhoz, RR, Kuk, D, Ott, PA, Johnson, DB, Tsai, KK, Rapisuwon, S, Eroglu, Z, Sullivan, RJ, Luke, JJ, Gangadhar, TC, Salama, AKS, Clark, V, Burias, C, Puzanov, I, Atkins, MB, Algazi, AP, Ribas, A, Wolchok, JD, and Postow, MA. "The efficacy of anti-PD-1 agents in acral and mucosal melanoma." Cancer 122, no. 21 (November 2016): 3354-3362.

PMID
27533633
Full Text

Schadendorf, D, Dummer, R, Hauschild, A, Robert, C, Hamid, O, Daud, A, van den Eertwegh, A, Cranmer, L, O'Day, S, Puzanov, I, Schachter, J, Blank, C, Salama, A, Loquai, C, Mehnert, JM, Hille, D, Ebbinghaus, S, Kang, SP, Zhou, W, and Ribas, A. "Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma." European journal of cancer (Oxford, England : 1990) 67 (November 2016): 46-54.

PMID
27596353
Full Text

Hodi, FS, Chesney, J, Pavlick, AC, Robert, C, Grossmann, KF, McDermott, DF, Linette, GP, Meyer, N, Giguere, JK, Agarwala, SS, Shaheen, M, Ernstoff, MS, Minor, DR, Salama, AK, Taylor, MH, Ott, PA, Horak, C, Gagnier, P, Jiang, J, Wolchok, JD, and Postow, MA. "Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial." The Lancet. Oncology 17, no. 11 (November 2016): 1558-1568.

PMID
27622997
Full Text

Salama, AKS, and Moschos, SJ. "Next Steps in Immuno-Oncology: Enhancing Antitumor Effects Through Appropriate Patient Selection and Rationally Designed Combination Strategies." Annals of oncology : official journal of the European Society for Medical Oncology (October 13, 2016).

PMID
27742649
Scholars@Duke

Choe, JH, Andonian, BJ, Kim, GJ, and Salama, AK. "Autoimmune meningoencephalitis in a melanoma patient treated with ipilimumab." Immunotherapy 8, no. 10 (October 2016): 1163-1167.

PMID
27605066
Full Text

Pages